FormulaFolio Investments’s Halozyme HALO Stock Holding History

FormulaFolio Investments’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-60,325	Closed	-$2.58M	–	600
2020 Q4	$2.58M	Buy	60,325 +15	+0%	+$539	0.05%	221
2020 Q3	$1.58M	Hold	60,310	–	–	0.06%	119
2020 Q2	$1.62M	Hold	60,310	–	–	0.07%	109
2020 Q1	$1.08M	Hold	60,310	–	–	0.06%	115
2019 Q4	$1.07M	Hold	60,310	–	–	0.04%	166
2019 Q3	$935K	Hold	60,310	–	–	0.04%	160
2019 Q2	$1.04M	Sell	60,310 -43,568	-42%	-$703K	0.04%	134
2019 Q1	$1.67M	Buy	+103,878	New	+$1.68M	0.07%	97

Other funds holding HALO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

FormulaFolio Investments's HALO Position: Q1 2021 in Review

FormulaFolio Investments sold out of Halozyme (HALO) in Q1 2021, closing a stake of 60,325 shares — an estimated $2.58M sold.

FormulaFolio Investments first reported a position in HALO in Q1 2019 and held it in 8 quarters. The position peaked at $2.58M in Q4 2020. 336 funds tracked by Wall St. Rank hold HALO as of Q1 2021.

FormulaFolio Investments reported no remaining Halozyme position as of Q1 2021 after selling out during the quarter.
FormulaFolio Investments sold 60,325 Halozyme shares in Q1 2021, an estimated $2.58M.
FormulaFolio Investments first reported a position in Halozyme in Q1 2019 and held it in 8 quarters.
FormulaFolio Investments's Halozyme position peaked at $2.58M in Q4 2020.
336 funds tracked by Wall St. Rank held Halozyme as of Q1 2021.

Based on FormulaFolio Investments's 13F filing for Q1 2021, filed 28 May 2021.